@article{TLCR22760,
author = {Niki Karachaliou and Manuel Fernandez-Bruno and Rafael Rosell},
title = {Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy. The most commonly used regimens are carboplatin and paclitaxel, carboplatin and protein-bound paclitaxel (nab-paclitaxel), and cisplatin and gemcitabine.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/22760}
}